31 results
CORRESP
LEGN
Legend Biotech Corp
21 May 20
Correspondence with SEC
12:00am
and collaboration agreement, both the Group and the customer jointly perform research and development activities and share the related costs … represents revenue recognized for the right to use the license in non-US territories, which was transferred in 2018 when the customer is able to use
6-K
EX-99.2
LEGN
Legend Biotech Corp
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
non-current time deposits.
Information about major customer
Revenue of US$40.8 million and US$13.7 million for the three months ended March 31 … , 2022 and 2021, respectively, was derived from sales to a single customer.
Revenue of US$0.04 million and nil for the three months ended March 31, 2022
6-K
LEGN
Legend Biotech Corp
23 Aug 21
Current report (foreign)
8:16am
on the locations of assets.
Information about major customer
Revenue of US$23,146,000 and US$33,915,000 for the six months ended June 30, 2020 and 2021 … , respectively, was derived from sales to a single customer.
4. REVENUE, OTHER INCOME AND GAINS
An analysis of revenue is as follows:
Six months
6-K
EX-99.2
LEGN
Legend Biotech Corp
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
The non-current asset information above is based on the locations of assets.
Information about major customer
Revenue of US$47.8 million and US … $34.9 million for the nine months ended September 30, 2021 and 2020, respectively, was derived from sales to a single customer. Revenue of US$3.0 million
F-1/A
EX-99.1
rx6708
29 May 20
Registration statement (foreign) (amended)
8:32am
6-K
EX-99.1
2r739l mwo0
3 Apr 23
Legend Biotech 6-K
4:01pm
F-1
EX-10.3
dw8m e4dc9
13 May 20
Registration statement (foreign)
4:41pm
6-K
EX-99.1
1mm8nd
16 Nov 21
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
mkc3g vyu0ds
23 Aug 21
Legend Biotech Corporation 6-K
8:00am
6-K
EX-99.3
9xz1k8gcr1kauzo1f67
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-99.3
wdlu5y9jc ko
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-10.1
iop3cp
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
6-K
EX-10.1
vv6rg2
3 Oct 22
Legend Biotech Corporation 6-K
4:02pm
20-F
x90gqqs6c
2 Apr 21
Annual report (foreign)
8:10am
6-K
21y i0deu
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
6-K
n703k5rnb3zvn5wh0b
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
DRS/A
z8um8gv
20 Apr 20
Draft registration statement (amended)
12:00am